홈
메리트
Happiness of mankind through the treatment
development of rare & incurable diseases
development of rare & incurable diseases
-
MarketTarget rare & incurable disease markets with high potential future growth
-
PipelineHigh-value Pipeline that is distinctly competitive with a high success rate
-
Human
ResourceResearchers formed of topic experts with ample successful R&D experience
PIPELINE
IR news
-
TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B PatientsTU7710 has the potential to be a highly effective and long-acting treatment for bleeding episodes a..
-
TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer- TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab..
-
[In the News] With three lead assets, Tiumbio tackles rare and incurable diseasesThe article, 'With three lead assets, Tiumbio tackles rare and incurable diseases' featured TiumBio...
Investment Information
-
CareersAt Tiumbio, we are seeking smart and talented individuals to join our team
-
- From previous day
- 280▲
- Fluctuation rate
- 3.76%
- Transaction volume
- 86,232
-
Stock informationPublic information